A scientist wearing lab attire and looking forward

Making a Profound Impact, Together

As an early pioneer of microbiome science, OpenBiome has changed the landscape of healthcare. Along with our clinical and research partners, we use microbiome-based approaches to find research solutions for pressing public health issues.

Advancing Medical Science Worldwide

DSC07705

Microbiome-based therapies are a new frontier of medicine that present a promising option for patients who have exhausted standard treatments.

Since 2012, OpenBiome has provided more than 70,000 investigational fecal microbiota transplantation (FMT) preparations for patients with antibiotic-resistant C. difficile.

We’ve also pushed the boundaries of science by supporting clinical trials including THRIVE — the first FMT-focused clinical trial in Africa and the first to evaluate microbiome manipulation in children with malnutrition.

Transforming Healthcare Through Investigational Fecal Microbiota Transplantation

ClinicalTrialDesign
+

Healthcare facilities and research institutions in the United States have partnered with OpenBiome to provide access to investigational FMT under an IND for patients and perform clinical trials.

Mission_Icon2
+

Patients with recurrent C. difficile infections have received urgently needed investigational fecal microbiota transplantation (FMT) preparations from OpenBiome.

An illustration of a scientist with various lab equipment
+

Clinical trials exploring the therapeutic potential of the microbiome have received guidance and investigational FMT preparations provided by OpenBiome.

Help us build a world where the full potential of the microbiome radically improves health for all

Scroll To Top